A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells

S Rupp, AM Zeiher, S Dimmeler, T Tonn… - The Journal of heart and …, 2010 - Elsevier
Novel surgical strategies have dramatically improved the initial outcome of newborns with
hypoplastic left heart syndrome. However, the single systemic right ventricle remains a major …

[HTML][HTML] Stem cell therapies in patients with single ventricle physiology

S Tarui, S Sano, H Oh - Methodist DeBakey cardiovascular journal, 2014 - ncbi.nlm.nih.gov
Single ventricle physiology, especially hypoplastic left heart syndrome, is one of the most
high-risk lesions in children with congenital heart disease, and the ensuing heart failure …

[HTML][HTML] Cardiac tissue engineering for the treatment of hypoplastic left heart syndrome (HLHS)

R Abraham, L Vricella, N Hibino - Translational pediatrics, 2023 - ncbi.nlm.nih.gov
Hypoplastic left heart syndrome (HLHS) is a deadly congenital heart disease that arises
when the left ventricle and outflow tract fail to develop appropriately, inhibiting the adequate …

[HTML][HTML] Cardiac regenerative capacity is age-and disease-dependent in childhood heart disease

A Traister, R Patel, A Huang, S Patel, J Plakhotnik… - PloS one, 2018 - journals.plos.org
Objective We sought to define the intrinsic stem cell capacity in pediatric heart lesions, and
the effects of diagnosis and of age, in order to inform evidence-based use of potential …

Stem cell therapy for congenital heart disease: a systematic review

DI Tsilimigras, EK Oikonomou, D Moris, D Schizas… - Circulation, 2017 - Am Heart Assoc
Background: Congenital heart disease (CHD) constitutes the most prevalent and
heterogeneous group of congenital anomalies. Although surgery remains the gold standard …

Stem cell therapies for congenital heart disease

M Ghafarzadeh, M Namdari, A Eatemadi - Biomedicine & Pharmacotherapy, 2016 - Elsevier
Congenital heart disease (CHD) is the most prevalent congenital anomaly in newborn
babies. Cardiac malformations have been induced in different animal model experiments, by …

[HTML][HTML] Current state of the art in hypoplastic left heart syndrome

AK Birla, S Brimmer, WD Short, OO Olutoye… - Frontiers in …, 2022 - frontiersin.org
Hypoplastic left heart syndrome (HLHS) is a complex congenital heart disease in which a
neonate is born with an underdeveloped left ventricle and associated structures. Without …

Potential for stem cell use in congenital heart disease

ES Pincott, M Burch - Future Cardiology, 2012 - Future Medicine
This article reports on the evolving field of stem cell therapy and its impact on the
management of cardiac pathology, in particular congenital heart disease. To date, stem cell …

[HTML][HTML] Challenges to success in heart failure: cardiac cell therapies in patients with heart diseases

H Oh, H Ito, S Sano - Journal of cardiology, 2016 - Elsevier
Heart failure remains the leading cause of death worldwide, and is a burgeoning problem in
public health due to the limited capacity of postnatal hearts to self-renew. The …

[HTML][HTML] Regenerative therapies in young hearts with structural or congenital heart disease

I Michel-Behnke, I Pavo, S Recla, M Khalil… - Translational …, 2019 - ncbi.nlm.nih.gov
Pediatric heart failure (HF) is rare. The prognosis is generally poor. HF is most frequently
related to cardiomyopathy or congenital heart disease (CHD). Associated phenotypes are …